FNY Partners Fund’s CareDx CDNA Stock Holding History

FNY Partners Fund’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,000	Closed	-$102K	–	374
2017 Q4	$102K	Buy	+14,000	New	+$87.3K	0.02%	200

Other funds holding CDNA

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Private Wealth Partners Mill Valley, California $1.4B AUM 36.82% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FNY Partners Fund's CDNA Position: Q1 2018 in Review

FNY Partners Fund sold out of CareDx (CDNA) in Q1 2018, closing a stake of 14,000 shares — an estimated $102K sold.

FNY Partners Fund first reported a position in CDNA in Q4 2017 and held it in 1 quarter. The position peaked at $102K in Q4 2017. 73 funds tracked by Wall St. Rank hold CDNA as of Q1 2018.

FNY Partners Fund reported no remaining CareDx position as of Q1 2018 after selling out during the quarter.
FNY Partners Fund sold 14,000 CareDx shares in Q1 2018, an estimated $102K.
FNY Partners Fund first reported a position in CareDx in Q4 2017 and held it in 1 quarter.
FNY Partners Fund's CareDx position peaked at $102K in Q4 2017.
73 funds tracked by Wall St. Rank held CareDx as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.